1
|
Pepió Vilaubí JM, Orozco-Beltrán D, Gonçalves AQ, Rodriguez Cumplido D, Aguilar Martin C, Lopez-Pineda A, Gil-Guillen VF, Quesada JA, Carratala-Munuera C. Adherence to European Clinical Practice Guidelines for Secondary Prevention of Cardiovascular Disease: A Cohort Study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2018; 15:ijerph15061233. [PMID: 29891821 PMCID: PMC6025527 DOI: 10.3390/ijerph15061233] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/10/2018] [Revised: 05/31/2018] [Accepted: 06/07/2018] [Indexed: 01/21/2023]
Abstract
To provide a better understanding of the actions taken within health systems and their results, this study aims to assess clinicians’ adherence to clinical practice guidelines (CPGs) regarding recommended treatments in patients with cardiovascular disease in primary care settings, and to determine the associated factors. We conducted an ambispective cohort study in 21 primary care centres in 8 Spanish regions. Patients diagnosed with coronary heart disease, stroke and/or peripheral arterial disease were included. Patients who received the treatment recommended in the European guidelines on cardiovascular disease prevention (CPG’s adherent group) were compared with patients who did not (CPG’s non-adherent group). The outcome variables were cardiovascular hospital admissions, all-cause and cardiovascular mortality during follow-up. Of the 438 participants, 38.6% (n = 169) received the drug therapies recommended in the guidelines. The factors that increased the likelihood of good adherence to CPG’s were being diagnosed with hypertension (p = 0.001), dyslipidaemia (p < 0.001) or diabetes (p = 0.001), and not having a psychiatric disorder (p = 0.005). We found no statistically significant association between good adherence to CPG’s and lower incidence of events (p = 0.853). Clinician adherence to guidelines for secondary prevention of cardiovascular disease was low in the primary care setting.
Collapse
Affiliation(s)
- Josep Maria Pepió Vilaubí
- Equip d'Atenció Primària Tortosa Oest, Institut Català de la Salut, 43500 Tortosa, Tarragona, Spain.
| | - Domingo Orozco-Beltrán
- Chair of Family Medicine, Miguel Hernandez University, 03550 San Juan de Alicante, Spain.
| | - Alessandra Queiroga Gonçalves
- Unitat de Suport a la Recerca Terres de l'Ebre, Institut Universitari d'Investigació en Atenció Primària (IDIAP) Jordi Gol, 43500 Tortosa, Tarragona, Spain.
- Unitat Docent de Medicina de Família i Comunitària Tortosa-Terres de l'Ebre, Institut Català de la Salut, 43500 Tortosa, Tarragona, Spain.
| | - Dolors Rodriguez Cumplido
- Fundació Institut Català de Farmacologia, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
| | - Carina Aguilar Martin
- Unitat de Suport a la Recerca Terres de l'Ebre, Institut Universitari d'Investigació en Atenció Primària (IDIAP) Jordi Gol, 43500 Tortosa, Tarragona, Spain.
- Unitat d'Avaluació, Direcció d'Atenció Primària Terres de l'Ebre, Institut Català de la Salut, 43500 Tortosa, Tarragona, Spain.
| | - Adriana Lopez-Pineda
- Chair of Family Medicine, Miguel Hernandez University, 03550 San Juan de Alicante, Spain.
| | - Vicente F Gil-Guillen
- Chair of Family Medicine, Miguel Hernandez University, 03550 San Juan de Alicante, Spain.
| | - Jose A Quesada
- Chair of Family Medicine, Miguel Hernandez University, 03550 San Juan de Alicante, Spain.
| | | |
Collapse
|